title: Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
abstract: Human insulin-like growth factor (IGF)-II mRNA has been shown to be expressed at high levels in a variety of tumors, including rhabdomyosarcomas. In addition, many tumors have alterations in p53 expression. To investigate whether p53 regulates IGF-II gene expression, we transfected wild-type p53 expression vectors and luciferase constructs driven by IGF-II P3 promotors into multiple cell lines. We found that p53 reduced, in a dose-dependent manner, both endogenous IGF-II P3 transcripts and transfected P3 luciferase expression. The inhibition of P3 luciferase expression by p53 was more pronounced in the two cell lines that expressed mutant p53 protein, RD, and HTB114. The element responsible for this inhibition was mapped to the minimal promoter region. We also transfected an HPV-16 E6 expression plasmid into CCL13 cells containing functional p53 and found that E6 up-regulated IGF-II P3 activity. Wild-type, but not mutant, p53 interfered with the binding of TATA-binding protein to the TATA motif of P3, although both could directly associate with human TATA-binding protein. Our results suggest that p53 may play a role in regulation of IGF-II gene expression.
authors.affiliation: Molecular Oncology Section, Pediatric Branch, National Cancer Institute, National Institutes ofHealth, Bethesda, Maryland 20892-1928, USA.
authors.forename: L
authors.initials: L
authors.lastname: Zhang
authors.forename: F
authors.initials: F
authors.lastname: Kashanchi
authors.forename: Q
authors.initials: Q
authors.lastname: Zhan
authors.forename: S
authors.initials: S
authors.lastname: Zhan
authors.forename: J N
authors.initials: JN
authors.lastname: Brady
authors.forename: A J
authors.initials: AJ
authors.lastname: Fornace
authors.forename: P
authors.initials: P
authors.lastname: Seth
authors.forename: L J
authors.initials: LJ
authors.lastname: Helman
mesh_terms: D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D016158:Genes, p53 / Q000502:physiology*; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics* / Q000378:metabolism; D007890:Leiomyosarcoma / Q000235:genetics / Q000378:metabolism; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D009154:Mutation / Q000235:genetics; D027383:Papillomaviridae / Q000737:chemistry; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012208:Rhabdomyosarcoma / Q000235:genetics* / Q000378:metabolism; D016385:TATA Box / Q000187:drug effects; D014162:Transfection; D014407:Tumor Cells, Cultured; D015854:Up-Regulation; D014764:Viral Proteins / Q000502:physiology
chemical_list: D014764:Viral Proteins; D007335:Insulin-Like Growth Factor II; D008156:Luciferases